Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Quest Diagnostics Inc. buy Mizuho

Start price
€123.34
17.03.23 / 50%
Target price
€155.08
17.03.24
Performance (%)
-4.33%
End price
€118.00
18.03.24
Summary
This prediction ended on 18.03.24 with a price of €118.00. With a performance of -4.33%, the BUY prediction by Mizuho finished with a loss. Mizuho has a follow-up prediction for Quest Diagnostics Inc. where he still thinks Quest Diagnostics Inc. is a Buy. Dividends of €2.62 are taken into consideration when calculating the performance. Mizuho has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Quest Diagnostics Inc. 6.678% 6.678% -3.381%
iShares Core DAX® 2.594% -1.158% 14.782%
iShares Nasdaq 100 3.553% -1.727% 43.265%
iShares Nikkei 225® 0.687% -8.354% 18.454%
iShares S&P 500 2.209% -0.942% 31.361%

Comments by Mizuho for this prediction

In the thread Quest Diagnostics Inc. diskutieren
Prediction Buy
Perf. (%) -4.33%
Target price 155.084
Change
Ends at 17.03.24

Quest Diagnostics Incorporated (NYSE: DGX) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $165.00 price target on the stock.
Ratings data for DGX provided by MarketBeat

In the thread Trading Quest Diagnostics Inc.
Prediction Buy
Perf. (%) -4.33%
Target price 155.084
Change
Ends at 17.03.24

Die von Mizuho gewählte maximale Laufzeit wurde überschritten

Current prediction by Mizuho for Quest Diagnostics Inc.

buy
Quest Diagnostics Inc.

Start price
Target price
Perf. (%)
€128.60
24.04.24
€145.02
24.04.25
0.00%
24.04.24